Ornithine carbamoyltransferase deficiency: genes and variants
Explore variant evidence for Ornithine carbamoyltransferase deficiency across 1 analyzed protein (OTC). Linked ClinVar records include 135 pathogenic or likely pathogenic variants, 106 variants of uncertain significance and 35 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Ornithine carbamoyltransferase deficiency
OTC: Ornithine transcarbamylase, mitochondrial
It combines ornithine with carbamoyl phosphate in the mitochondrial urea cycle, allowing toxic nitrogen to be converted ultimately to urea. Loss-of-function variants cause X-linked OTC deficiency and can produce life-threatening hyperammonemia.
135 ClinVar pathogenic / likely pathogenic and 141 uncertain variants in OTC have source records linked to Ornithine carbamoyltransferase deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Ornithine carbamoyltransferase deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| OTC R26Q | 26 | Pathogenic / likely pathogenic (★★★★) | |
| OTC P225L | 225 | Pathogenic / likely pathogenic (★★) | |
| OTC R277Q | 277 | Pathogenic / likely pathogenic (★★) | |
| OTC R277W | 277 | Pathogenic / likely pathogenic (★★) | |
| OTC R40C | 40 | Pathogenic / likely pathogenic (★★) | |
| OTC R141Q | 141 | Pathogenic / likely pathogenic (★★) | |
| OTC P169L | 169 | Pathogenic / likely pathogenic (★★) | |
| OTC G188R | 188 | Pathogenic / likely pathogenic (★★) | |
| OTC W193R | 193 | Pathogenic / likely pathogenic (★★) | |
| OTC G195R | 195 | Pathogenic / likely pathogenic (★★) | |
| OTC D196N | 196 | Pathogenic / likely pathogenic (★★) | |
| OTC M205T | 205 | Pathogenic / likely pathogenic (★★) | |
| OTC M206R | 206 | Pathogenic / likely pathogenic (★★) | |
| OTC M206K | 206 | Pathogenic / likely pathogenic (★★) | |
| OTC K210E | 210 | Pathogenic / likely pathogenic (★★) | |
| OTC P225S | 225 | Pathogenic / likely pathogenic (★★) | |
| OTC R40L | 40 | Pathogenic / likely pathogenic (★★) | |
| OTC R40H | 40 | Pathogenic / likely pathogenic (★★) | |
| OTC R129H | 129 | Pathogenic / likely pathogenic (★★) | |
| OTC M206I | 206 | Pathogenic / likely pathogenic (★★) | |
| OTC S207R | 207 | Pathogenic / likely pathogenic (★★) | |
| OTC M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| OTC K80E | 80 | Pathogenic / likely pathogenic (★★) | |
| OTC S81P | 81 | Pathogenic / likely pathogenic (★★) | |
| OTC L139S | 139 | Pathogenic / likely pathogenic (★★) | |
| OTC P158L | 158 | Pathogenic / likely pathogenic (★★) | |
| OTC I159M | 159 | Pathogenic / likely pathogenic (★★) | |
| OTC T178M | 178 | Pathogenic / likely pathogenic (★★) | |
| OTC G197R | 197 | Pathogenic / likely pathogenic (★★) | |
| OTC N199S | 199 | Pathogenic / likely pathogenic (★★) | |
| OTC A209V | 209 | Pathogenic / likely pathogenic (★★) | |
| OTC A233V | 233 | Pathogenic / likely pathogenic (★★) | |
| OTC S340F | 340 | Pathogenic / likely pathogenic (★★) | |
| OTC I53T | 53 | Pathogenic / likely pathogenic (★★) | |
| OTC R92Q | 92 | Pathogenic / likely pathogenic (★★) | |
| OTC E122G | 122 | Pathogenic / likely pathogenic (★★) | |
| OTC N161S | 161 | Pathogenic / likely pathogenic (★★) | |
| OTC Y183C | 183 | Pathogenic / likely pathogenic (★★) | |
| OTC D263G | 263 | Pathogenic / likely pathogenic (★★) | |
| OTC L304F | 304 | Pathogenic / likely pathogenic (★★) | |
| OTC R330G | 330 | Pathogenic / likely pathogenic (★★) | |
| OTC K221N | 221 | Pathogenic / likely pathogenic (★★) | |
| OTC E239D | 239 | Pathogenic / likely pathogenic (★★) | |
| OTC R141P | 141 | Pathogenic / likely pathogenic (★) | |
| OTC P225Q | 225 | Pathogenic / likely pathogenic (★) | |
| OTC G39V | 39 | Pathogenic / likely pathogenic (★) | |
| OTC L45R | 45 | Pathogenic / likely pathogenic (★) | |
| OTC I160F | 160 | Pathogenic / likely pathogenic (★) | |
| OTC G162R | 162 | Pathogenic / likely pathogenic (★) | |
| OTC G162V | 162 | Pathogenic / likely pathogenic (★) | |
| OTC L163Q | 163 | Pathogenic / likely pathogenic (★) | |
| OTC H168Y | 168 | Pathogenic / likely pathogenic (★) | |
| OTC H168R | 168 | Pathogenic / likely pathogenic (★) | |
| OTC P169S | 169 | Pathogenic / likely pathogenic (★) | |
| OTC P169A | 169 | Pathogenic / likely pathogenic (★) | |
| OTC Q180P | 180 | Pathogenic / likely pathogenic (★) | |
| OTC Q180H | 180 | Pathogenic / likely pathogenic (★) | |
| OTC G188V | 188 | Pathogenic / likely pathogenic (★) | |
| OTC W193C | 193 | Pathogenic / likely pathogenic (★) | |
| OTC D196Y | 196 | Pathogenic / likely pathogenic (★) |
Showing 60 of 135.
Uncertain variants prioritized for review in Ornithine carbamoyltransferase deficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| OTC M268I | 268 | Conflicting reports (★) | +7: M268K at the same position is pathogenic; seen in 8.9e-06 of gnomAD DNA copies; REVEL 0.944 | |
| OTC G39D | 39 | Conflicting reports (★) | +7: 6 other pathogenic changes within 3 positions; G39V at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.834 | |
| OTC A140V | 140 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; A140P at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.823 | |
| OTC D126E | 126 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; D126N at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.905 | |
| OTC T343I | 343 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; T343R at the same position is pathogenic; seen in 9.2e-07 of gnomAD DNA copies; REVEL 0.780 | |
| OTC G162A | 162 | Conflicting reports (★) | +7: 9 other pathogenic changes within 3 positions; G162R at the same position is pathogenic; seen in 9.2e-07 of gnomAD DNA copies; REVEL 0.812 | |
| OTC D126G | 126 | Uncertain (★) | +7: 2 other pathogenic changes within 3 positions; D126N at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.980 | |
| OTC S164P | 164 | Uncertain (★) | +7: 6 other pathogenic changes within 3 positions; S164L at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.966 | |
| OTC S203F | 203 | Conflicting reports (★) | +6: 11 other pathogenic changes within 3 positions; S203P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| OTC M205R | 205 | Uncertain (★) | +6: 11 other pathogenic changes within 3 positions; M205K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 | |
| OTC P158R | 158 | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; P158L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91 | |
| OTC D175N | 175 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; D175Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 | |
| OTC P347R | 347 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; P347T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.74 | |
| OTC R129C | 129 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; R129H at the same position is pathogenic; REVEL 0.908 | |
| OTC A209G | 209 | Uncertain (★★) | +6: 10 other pathogenic changes within 3 positions; A209E at the same position is pathogenic; REVEL 0.836 | |
| OTC S81F | 81 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; S81P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.70 |
Which prediction tools work for Ornithine carbamoyltransferase deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 93 out of 100
- ESM1b (LLR): 90 out of 100
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 84 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 82 out of 100
Diseases related to Ornithine carbamoyltransferase deficiency
- Likely inborn error of metabolism, also linked to OTC
Frequently asked questions
Which genes have records linked to Ornithine carbamoyltransferase deficiency?
This view contains 1 analyzed proteins: OTC. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 135 pathogenic or likely pathogenic variants, 106 variants of uncertain significance and 35 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 16 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 312 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center